{"id":"https://openalex.org/G2014468658","display_name":"Treatment strategy of Lewy body disease by activation of intracellular degradation system","description":"The accumulation of mis-folded and/or abnormally modified proteins is a major characteristic of many neurodegenerative diseases. In Lewy body disease (LBD), insoluble \u03b1-synuclein is widely deposited in the presynaptic terminals as well as in the neuronal cytoplasm in distinct brain regions. The autophagy-lysosome system is an efficient degradation pathway for abnormal molecules within cells. We investigated the effect of trehalose on abnormal aggregation of \u03b1-synuclein in a model of LBD. Trehalose treatment induced autophagy and reduced level of detergent-insoluble \u03b1-synuclein, although an apparent alteration was not observed in abnormal aggregation of \u03b1-synuclein. These results indicate that the oral intake of trehalose can be a promissing treatment for prevention of accumulation of abnormal \u03b1-synuclein, especially before aggregation formation.","funder_award_id":"26860655","funder":{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","doi":"https://doi.org/10.13039/501100001691"},"funded_outputs":["https://openalex.org/W1138002109","https://openalex.org/W1551907283","https://openalex.org/W1708271940","https://openalex.org/W1802924131","https://openalex.org/W1905994174","https://openalex.org/W1924933058","https://openalex.org/W2136895796","https://openalex.org/W2163840174","https://openalex.org/W2166363953","https://openalex.org/W2179131711","https://openalex.org/W2280864985","https://openalex.org/W2288569820"],"funded_outputs_count":12,"parent_awards":[],"sub_awards":[],"sub_awards_count":0,"amount":2990000.0,"currency":"JPY","amount_usd":28928.72,"amount_usd_basis":"daily_rate","recipients":[],"recipient_countries":[],"recipient_regions":[],"research_scope":{"is_research":true,"basis":"funder_default","tier":1},"funding_type":"fellowship","funder_scheme":"Grant-in-Aid for Young Scientists (B)","start_date":"2014-04-01","end_date":"2016-03-31","start_year":2014,"end_year":2016,"landing_page_url":"https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-26860655/","doi":null,"provenance":"kaken","lead_investigator":{"given_name":"Yasuo","family_name":"Miki","orcid":null,"role_start":null,"affiliation":{"name":"Hirosaki University","country":"Japan","ids":[{"id":"https://nrid.nii.ac.jp/nrid/1000030709142","type":"nrid","asserted_by":"kaken"}]},"author":{"id":"https://openalex.org/A5087612801","display_name":"Yasuo Miki","orcid":"https://orcid.org/0000-0001-9375-9590"},"institutions":[{"id":"https://openalex.org/I146516829","display_name":"Hirosaki University","ror":"https://ror.org/02syg0q74","country_code":"JP","type":"education","lineage":["https://openalex.org/I146516829"]}]},"co_lead_investigator":null,"investigators":null,"works_api_url":"https://api.openalex.org/works?filter=awards.id:G2014468658","primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.998,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.998,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10587","display_name":"Autophagy in Disease and Therapy","score":0.0008,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.0002,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lewy-body-disease","display_name":"Lewy body disease","score":0.998},{"id":"https://openalex.org/keywords/alpha-synuclein","display_name":"alpha-synuclein","score":0.875},{"id":"https://openalex.org/keywords/trehalose","display_name":"trehalose","score":0.978},{"id":"https://openalex.org/keywords/autophagy","display_name":"autophagy","score":0.944},{"id":"https://openalex.org/keywords/autophagy-lysosome-system","display_name":"autophagy-lysosome system","score":0.945},{"id":"https://openalex.org/keywords/protein-aggregation","display_name":"protein aggregation","score":0.834},{"id":"https://openalex.org/keywords/neurodegenerative-diseases","display_name":"neurodegenerative diseases","score":0.794},{"id":"https://openalex.org/keywords/protein-degradation","display_name":"protein degradation","score":0.458}],"sustainable_development_goals":[{"score":0.9763,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"institution_awarded":[{"id":"https://openalex.org/I146516829","display_name":"Hirosaki University","ror":"https://ror.org/02syg0q74","country_code":"JP","type":"education","lineage":["https://openalex.org/I146516829"]}],"updated_date":"2026-11-13T03:01:57.000Z","created_date":"2026-07-13T04:17:19.000Z"}
